Strategic time for tech and biotech

kris walesby ETF Securities ETFs ETF covid-19 technology biotechnology

23 March 2020
| By Chris Dastoor |
image
image
expand image

With the current volatility, now is the best time to look for stocks or exchange traded funds (ETFs) that are helping keep what’s left of the economy running, like technology and biotech.

Kris Walesby, ETF Securities chief executive, said internet providers, web conferencing, mobile, social media and online shopping stocks were the best examples.

“Netflix has had subscription spike in areas particularly hard hit by COVID-19, while Amazon has actually had to hire more people to manage their warehouses to cope with increased demand for delivery,” Walesby said.

“Netflix has also trialled a function to allow ‘Netflix parties’ which is an excellent opportunity to battle social isolation.

“Biotechnology companies globally are racing for the solution – it’s a bit of a lottery as to who will manage first – but worth noting the following: Moderna started clinical trials on a vaccine this week and Gilead’s anti-viral medications are looking promising as treatments.”

Biotech had previously been considered a volatile sector but was more valuable in the current environment.

“It’s fair to say in our increasingly global world, COVID-19 is not going to be the last time we have to take drastic measures to limit the spread of a pandemic virus and these companies have been positioned to step up quickly because of their ongoing work,” Walesby said.

Walesby shared a few other tips: “Generally agreed lessons from this period for investors include: 1. don’t sell quality assets in panic and at unreasonably low levels; 2. don’t try and pick the bottom; 3. consider slowly accumulating good assets at attractive prices and getting oneself positioned for the recovery, whenever it may come.”

Read more about:

AUTHOR

Recommended for you

sub-bgsidebar subscription

Never miss the latest news and developments in wealth management industry

MARKET INSIGHTS

Completely agree Peter. The definition of 'significant change is circumstances relevant to the scope of the advice' is s...

1 month 3 weeks ago

This verdict highlights something deeply wrong and rotten at the heart of the FSCP. We are witnessing a heavy-handed, op...

2 months ago

Interesting. Would be good to know the details of the StrategyOne deal....

2 months ago

SuperRatings has shared the median estimated return for balanced superannuation funds for the calendar year 2024, finding the year achieved “strong and consistent positiv...

2 weeks 2 days ago

Original bidder Bain Capital, which saw its first offer rejected in December, has returned with a revised bid for Insignia Financial....

1 week 2 days ago

The FAAA has secured CSLR-related documents under the FOI process, after an extended four-month wait, which show little analysis was done on how the scheme’s cost would a...

1 week ago

TOP PERFORMING FUNDS